See more : Easy Trip Planners Limited (EASEMYTRIP.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Kenvue Inc. (KVUE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kenvue Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Hyulim ROBOT Co.,Ltd. (090710.KQ) Income Statement Analysis – Financial Results
- Shoprite Holdings Limited (SRGHY) Income Statement Analysis – Financial Results
- SHL Telemedicine Ltd. (SHLT) Income Statement Analysis – Financial Results
- Larsen & Toubro Limited (LT.BO) Income Statement Analysis – Financial Results
- Luzerner Kantonalbank AG (0QNU.L) Income Statement Analysis – Financial Results
Kenvue Inc. (KVUE)
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 15.44B | 14.95B | 15.05B | 14.47B | 14.32B |
| Cost of Revenue | 6.80B | 6.67B | 6.64B | 6.62B | 6.66B |
| Gross Profit | 8.64B | 8.29B | 8.42B | 7.85B | 7.66B |
| Gross Profit Ratio | 55.96% | 55.42% | 55.93% | 54.25% | 53.49% |
| Research & Development | 399.00M | 375.00M | 355.00M | 320.00M | 391.00M |
| General & Administrative | 4.33B | 4.28B | 4.02B | 3.73B | 3.94B |
| Selling & Marketing | 1.35B | 1.36B | 1.46B | 1.23B | 1.26B |
| SG&A | 5.68B | 5.63B | 5.48B | 4.96B | 5.20B |
| Other Expenses | 50.00M | 4.00M | 25.00M | 3.00M | 59.00M |
| Operating Expenses | 6.13B | 5.62B | 5.41B | 4.86B | 5.26B |
| Cost & Expenses | 12.93B | 12.28B | 12.04B | 11.48B | 11.93B |
| Interest Income | 108.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 358.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 627.00M | 644.00M | 731.00M | 746.00M | 709.00M |
| EBITDA | 3.18B | 3.64B | 3.87B | 3.79B | 3.28B |
| EBITDA Ratio | 20.56% | 22.39% | 25.61% | 53.51% | 25.98% |
| Operating Income | 2.51B | 2.68B | 2.92B | -979.00M | 1.85B |
| Operating Income Ratio | 16.27% | 17.89% | 19.40% | -6.77% | 12.89% |
| Total Other Income/Expenses | -322.00M | -38.00M | 5.00M | -37.00M | 274.00M |
| Income Before Tax | 2.19B | 2.64B | 2.93B | -1.02B | 2.12B |
| Income Before Tax Ratio | 14.18% | 17.64% | 19.43% | -7.02% | 14.80% |
| Income Tax Expense | 526.00M | 550.00M | 894.00M | -137.00M | 685.00M |
| Net Income | 1.66B | 2.06B | 2.08B | -879.00M | 1.44B |
| Net Income Ratio | 10.77% | 13.81% | 13.80% | -6.08% | 10.02% |
| EPS | 0.90 | 1.08 | 1.08 | -0.47 | 0.76 |
| EPS Diluted | 0.87 | 1.08 | 1.08 | -0.47 | 0.76 |
| Weighted Avg Shares Out | 1.85B | 1.91B | 1.89B | 1.89B | 1.89B |
| Weighted Avg Shares Out (Dil) | 1.92B | 1.91B | 1.89B | 1.89B | 1.89B |
3 Dividend Aristocrats to Buy Today
4 Dividend Aristocrats To Buy In June And 4 To Watch
Kenvue Announces Participation in Deutsche Bank's dbAccess Global Consumer Conference
3 Healthcare Stocks to Buy Now: May 2024
Divide and Conquer: 3 Stock Spinoffs Set to Trounce the Market
Kenvue Announces Pricing of Secondary Offering
Johnson & Johnson Is Officially Getting Out of Kenvue (KVUE) Stock
Kenvue's stock falls after company announces 182.3 million secondary stock offering
Kenvue Announces Launch of Secondary Offering
4 Strong Buy Dividend Aristocrats Wall Street Loves Are Trading Just Above 52-Week Lows
Source: https://incomestatements.info
Category: Stock Reports